Xiangyu Medical Co.,Ltd (SHA:688626)
63.98
+1.00 (1.59%)
At close: Mar 6, 2026
Xiangyu Medical Co.,Ltd Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 743.18 | 663.78 | 726.31 | 829.62 |
Trading Asset Securities | - | - | 162.19 | 636.47 | 648.14 |
Cash & Short-Term Investments | 834.65 | 743.18 | 825.98 | 1,363 | 1,478 |
Cash Growth | 12.31% | -10.02% | -39.39% | -7.78% | 203.29% |
Accounts Receivable | - | 67.7 | 57.99 | 34.35 | 43.03 |
Other Receivables | - | 15.24 | 7.42 | 5 | 4.37 |
Receivables | - | 82.95 | 65.41 | 39.35 | 47.4 |
Inventory | - | 238.21 | 241.37 | 222.82 | 159.4 |
Prepaid Expenses | - | - | - | - | 1.78 |
Other Current Assets | - | 77.38 | 61.6 | 43.42 | 30.18 |
Total Current Assets | - | 1,142 | 1,194 | 1,668 | 1,717 |
Property, Plant & Equipment | - | 1,216 | 834.36 | 407.96 | 170.9 |
Long-Term Investments | - | 266.03 | 258.52 | 17.09 | 16.71 |
Other Intangible Assets | - | 216.89 | 207.7 | 204.25 | 208.78 |
Long-Term Accounts Receivable | - | 33.53 | 47.79 | 43.03 | 50.2 |
Long-Term Deferred Tax Assets | - | 9.55 | 11.22 | 14.7 | 11.4 |
Long-Term Deferred Charges | - | 16.57 | 5.72 | 1.51 | 1.47 |
Other Long-Term Assets | - | 27.14 | 32.47 | 11.15 | 6.57 |
Total Assets | - | 2,928 | 2,592 | 2,368 | 2,183 |
Accounts Payable | - | 135.62 | 109.69 | 103.87 | 27.71 |
Accrued Expenses | - | 60.56 | 62.61 | 45.46 | 33.49 |
Short-Term Debt | - | 354.1 | 27.02 | 17.15 | - |
Current Portion of Leases | - | 1.12 | - | - | - |
Current Income Taxes Payable | - | 1.45 | 5.06 | 2.01 | 8.71 |
Current Unearned Revenue | - | 127.97 | 107.56 | 135.69 | 64.23 |
Other Current Liabilities | - | 53.89 | 60.21 | 47.62 | 47.27 |
Total Current Liabilities | - | 734.71 | 372.14 | 351.8 | 181.42 |
Long-Term Leases | - | 11.14 | 8.44 | - | - |
Long-Term Unearned Revenue | - | 127.25 | 104.11 | 65.1 | 53.72 |
Long-Term Deferred Tax Liabilities | - | - | - | 11.31 | 1.83 |
Total Liabilities | - | 873.1 | 484.69 | 428.22 | 236.97 |
Common Stock | - | 160 | 160 | 160 | 160 |
Additional Paid-In Capital | - | 1,299 | 1,294 | 1,294 | 1,294 |
Retained Earnings | - | 756.04 | 735.7 | 546.36 | 480.83 |
Treasury Stock | - | -176.5 | -98.93 | -73.27 | - |
Total Common Equity | 2,027 | 2,039 | 2,091 | 1,928 | 1,935 |
Minority Interest | - | 16.1 | 16.53 | 12.27 | 10.53 |
Shareholders' Equity | 2,041 | 2,055 | 2,107 | 1,940 | 1,946 |
Total Liabilities & Equity | - | 2,928 | 2,592 | 2,368 | 2,183 |
Total Debt | 639.86 | 366.35 | 35.46 | 17.15 | - |
Net Cash (Debt) | 194.8 | 376.83 | 790.52 | 1,346 | 1,478 |
Net Cash Growth | -48.31% | -52.33% | -41.25% | -8.94% | 237.97% |
Net Cash Per Share | 1.26 | 2.42 | 5.01 | 8.47 | 9.88 |
Filing Date Shares Outstanding | 162.27 | 154.19 | 157.11 | 157.73 | 160 |
Total Common Shares Outstanding | 156.07 | 155.1 | 157.11 | 157.73 | 160 |
Working Capital | - | 407 | 822.21 | 1,317 | 1,535 |
Book Value Per Share | 12.99 | 13.14 | 13.31 | 12.22 | 12.09 |
Tangible Book Value | 1,816 | 1,822 | 1,883 | 1,723 | 1,726 |
Tangible Book Value Per Share | 11.63 | 11.75 | 11.99 | 10.93 | 10.79 |
Buildings | - | 884.79 | 326.28 | 96.84 | 96.84 |
Machinery | - | 173.84 | 146.98 | 61.96 | 52.32 |
Construction In Progress | - | 252.27 | 428.83 | 314.09 | 77.09 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.